Safety and Tolerability of ASA404 Administered in Combination With Docetaxel in Japanese Patients With Solid Tumors
Clinical trial NCT01285453 · COMPLETED
Trial details
- NCT number
- NCT01285453
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2009-12-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.